BD Achieves Historic Recognition in MedTech
On August 5, 2025, Becton, Dickinson and Company (BD), a leader in global medical technology, announced a major milestone in supply chain resilience. The company's Urology and Critical Care (UCC) and Surgery business units have become the first in the medical technology sector to attain a prestigious diamond-level rating from the Healthcare Industry Resilience Collaborative (HIRC). This rating spans all seven categories of supply chain resilience recognized by HIRC's Resiliency Badging program.
Achieving this diamond status is no small feat for BD. Tony Ezell, the executive vice president and president of the Americas region for BD, expressed pride in this accomplishment, emphasizing their commitment to building a robust, end-to-end supply chain across varied product lines. "Hundreds of millions of patients depend on BD," he stated, highlighting how this recognition reflects the tireless efforts of their team to ensure timely product availability and quality service.
HIRC, established in 2019 by a coalition of health care providers and trading partners, aims to enhance transparency and resilience within health care supply chains. Their Resiliency Badge Program features a thorough audit process assessing supply chain resilience against specific benchmarks for supply continuity, risk mitigation, and operational effectiveness.
After successfully completing this extensive audit, HIRC acknowledged BD for its exceptional resiliency across various domains crucial to successful supply chain management. These include:
- - Demand Planning: Ensuring that products are available when and where they are needed.
- - Supplier Management: Maintaining strong relationships and performance with suppliers.
- - Inventory Management: Effectively managing stock levels to meet demand without excess.
- - Logistics: Efficiently moving products through the supply chain.
- - Supply Chain Visibility: Providing insights into the supply chain status to all stakeholders.
- - Risk Management: Identifying and mitigating potential risks to the supply chain.
- - Contingency Planning: Preparing for unforeseen disruptions.
- - Operational Health: Assessing the overall performance and reliability of the operations.
BD previously received recognition as a Transparency Partner by HIRC in 2023, solidifying their status as a frontrunner in the medical technology field. The diamond-level designation not only adds to this recognition but also signals BD's ongoing commitment to strengthening its supply chain and manufacturing operations. This includes increasing safety stock and capacity for critical products and improving order management systems to provide customers with real-time supply and delivery insights.
In a world where health care providers face numerous challenges, BD remains dedicated to supporting the frontlines of health care. Their continued investment in innovative technology and processes aims to enhance the effectiveness and safety of care delivery. BD, along with more than 70,000 employees, strives to improve medical discovery and care delivery worldwide.
Through collaboration and innovation, BD tackles some of the most pressing global health issues, enhancing health outcomes, reducing costs, and expanding access to care. As the medical landscape continues to evolve, BD stands at the forefront, demonstrating that a focus on resilience can lead to recognition and reliability, essential for meeting the health needs of millions across the globe. For more information about BD, please visit
bd.com or connect with them on LinkedIn, Twitter, or Instagram.